Search results
Results from the WOW.Com Content Network
Art Fund sponsors the Museum of the Year award (known as the Gulbenkian Prize from 2003 to 2007 and the Art Fund Prize from 2008 to 2012). This is a £100,000 prize awarded annually to the museum or gallery that had the most imaginative, innovative or popular project during the previous year. [11]
In an analysis of the drug development costs for 98 companies over a decade, the average cost per drug developed and approved by a single-drug company was $350 million. [3] But for companies that approved between eight and 13 drugs over 10 years, the cost per drug went as high as $5.5 billion. [3]
Federal Reserve Economic Data ( FRED) is a database maintained by the Research division of the Federal Reserve Bank of St. Louis that has more than 816,000 economic time series from various sources. [1] They cover banking, business/fiscal, consumer price indexes, employment and population, exchange rates, gross domestic product, interest rates ...
Invesco Nasdaq 100 ETF (QQQM) This fund – also from Invesco – tracks the Nasdaq-100, too, but it does it at even lower cost. The fund has not existed for five years, but its three-year returns ...
At JLL, team members feel encouraged to try new ways forward, Ulbrich says. “Nobody gets fired for using the wrong path. You just have to have a good explanation and a good thought process why ...
Why stocks look so risky right now compared to risk-free Treasuries ... Harry's worried that stock prices keep rising while earnings go flat. ... because even my stalwarts like Coke and P&G are ...
Thomas Christian Südhof (German pronunciation: [ˈtoːmas ˈzyːtˌhoːf] ⓘ; born December 22, 1955), ForMemRS, is a German-American biochemist known for his study of synaptic transmission.
In 2020, FIND became a co-convener of the Diagnostics Pillar of the Access to COVID-19 Tools Accelerator with The Global Fund to Fight AIDS, Tuberculosis and Malaria. Together they supported the development of reliable rapid antigen tests for COVID-19, and guaranteed access to 120 million rapid tests at an affordable price to low- and middle ...